Department News : 2017 :

A Step Closer to Realizing the Promise of Precision Medicine in Cancer

New findings by researchers at Sylvester Comprehensive Cancer Center may prove to be an important solution to one of the more difficult problems faced in the field of precision medicine when it comes to treating cancer. An article reporting their findings, “Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies,” was published online November 9 by Scientific Reports.

Read more »

From left, Kerry L. Burnstein, Ph.D., Mai Huynh, Govindi Samaranayake, Rolando Lyles, Clara Troccoli, and Priyamvada Rai, Ph.D.

Sylvester Researchers and Colleagues Identify Novel Therapeutic Target for Incurable Prostate Cancer

A collaborative study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues has identified a novel therapeutic target for incurable prostate cancer. The research found a critical role for thioredoxin-1, a protein that protects cells from oxidative stress, in the progression of prostate cancer to the incurable castration-resistant stage.

Read more »

From left, Michael A. Kolber, M.D., Ph.D., Hansel Tookes, M.D., M.P.H., and Daniel J. Feaster, Ph.D.

NIDA Grant Awarded to Researchers to Identify Best Practices to Boost PrEP Adherence

An international collaboration among researchers in Miami, New York, and Montreal aims to determine the best strategies for effectively providing people who inject drugs with pre-exposure prophylaxis (PrEP) to protect them from HIV infection. Their efforts will be backed by an $8 million grant just awarded from the National Institute on Drug Abuse.

Read more »